Business Wire

THALES

11.6.2024 09:01:34 CEST | Business Wire | Press release

Share
Queensland Residents in Australia Embrace Digital Driver Licences Powered and Protected by Thales

The Queensland Digital Licence App has reached over 500,000 users since its launch on 1 November, 2023, showing a clear appetite from Queensland residents for safe and secure digital identity. Thales and Queensland Department of Transport and Main Roads (TMR) released the new app to all Queensland residents following a successful pilot and an extended trial in Townsville, where engagement with real end users, businesses, and industry groups provided valuable insights to the project in readiness for the launch.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611475244/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Credit: Queensland Department of Transport and Main Roads

With core technology provided by Thales, supported by development and operations from local partners Code Heroes and Aliva, the QLD Digital Licence app is simple to use, secure, and designed with data security and user privacy in mind. The app includes features such as multi-factor authentication, integration with the Queensland Digital Identity (QDI) service, and built-in verification for secure user-to-user information exchange. The app's consent-based design gives the individual control over their identity data – users can present or share information from the app by selecting from common use cases that disclose only the relevant information for the transaction, such as ‘proof of age’, which displays an ‘over 18’ screen without exposing date of birth, address, or driving information – a popular feature. The app currently provides digital driver licences, proof of age (18+) cards, and marine licences, with the potential for more digital documents in future.

Businesses that need to check identity or age requirements to provide goods or services can download the standalone (QLD) Verifier for Digital Licence app, which electronically confirms the authenticity of data received from a Digital Licence app. Digital verification is also expected to help businesses reduce the need to store sensitive identity data attributes as the process of verification is quick and simple, allowing for point-in-time verification in a wide range of use cases. The requirements to develop verification functionality are publicly available within the mobile driving licence app standard (ISO/IEC18013-5), allowing the larger ecosystem to build complementary verification solutions and enhance the usability of the digital licence in everyday life.

The QLD Digital Licence app and Verifier for Digital Licence app developed by Thales, are available now to Queensland residents via the mobile app stores.

“Nothing is more important that your private data, which should be highly protected. We are proud of the current success of the Queensland Digital Licence app, ensuring the safety and security of private information while offering a modern digital experience. The app undergoes rigorous privacy and information security testing to protect identity. It aligns with international standards for mobile driver licences, setting the standard for mobile driver licence apps across Australia and the world” commented Mark Bailey, Minister for Transport and Main Roads.

“Through this collaboration, Thales demonstrates a field-proven capacity to provide citizens with highly convenient and secure solutions, allowing them to reap the full benefits of digitalization. The Queensland Digital Licence App is a significant milestone in the digital ID market, showing the growing importance of and appetite for alignment to international standards for mobile driving licences and interoperability across country borders” said Youzec Kurp, Senior Vice President Identity and Biometric Solutions at Thales.

About Thales

Thales (Euronext Paris: HO) is a global leader in advanced technologies specialized in three business domains: Defence & Security, Aeronautics & Space, and Cybersecurity & Digital identity.

It develops products and solutions that help make the world safer, greener and more inclusive.

The Group invests close to €4 billion a year in Research & Development, particularly in key innovation areas such as AI, cybersecurity, quantum technologies, cloud technologies and 6G.

Thales has close to 81,000 employees in 68 countries. In 2023, the Group generated sales of €18.4 billion.

PLEASE VISIT

Thales Group
Digital Identity & Security

Thales
Thales Digital Identity and Security

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240611475244/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Landmark Global Galderma Survey Shows 9 out of 10 People Are Affected by Skin Quality Concerns7.7.2026 07:00:00 CEST | Press release

World’s most extensive skin quality profiling survey of more than 11,000 people across Europe, Asia, and the Americas finds that nine out of ten people are affected by skin quality concerns, with the most important attributes of good skin quality identified as smooth, hydrated and glowing skin1 Results show that skin quality has an impact on quality of life for 85% of people, with more than a third feeling self-conscious, insecure or anxious due to poor skin quality1 In response to clinicians’ calls for a universal assessment tool to help address these concerns, Galderma supported leading experts in the development of the Skin Quality Assessment Scale; a holistic, science-based tool to evaluate skin quality comprehensively and guide personalized, long-term treatment planning2 At Galderma, we champion skin quality by providing insights, tools, and solutions to better understand and address a wide spectrum of concerns, helping people take pride and feel comfortable in their own skin at e

Morinaga Milk Achieves Self-Affirmed GRAS Status for LAC-Living+™, Expanding U.S. Opportunities for Its Postbiotic Ingredient7.7.2026 04:00:00 CEST | Press release

Clinical evidence–backed postbiotic supports mood and well-being with formulation flexibility for diverse applications Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy and functional ingredient company, today announced that it has achieved self-affirmed GRAS (Generally Recognized As Safe) status in the United States for LAC-Living+™ (L. helveticus MCC1848), its proprietary postbiotic ingredient. This milestone expands the commercial availability of LAC-Living+ in the U.S. market and enables its use in dietary supplements, functional foods, and beverages, supporting the development of products designed to address growing consumer demand for health and well-being solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706806943/en/ Growing Interest in Postbiotics and Mental Well-Being Consumer interest in proactive health management has expanded significantly in recent years, alongside increasing aw

Access Advance Welcomes New Licensors to the Video Distribution Patent Pool7.7.2026 02:00:00 CEST | Press release

Access Advance LLC today announced that Sharp, M&K Holdings, Tagivan and 9 other patent owners who own substantial video codec patent portfolios that cover the core technologies behind video decoding, processing, and streaming media delivery, have joined the Video Distribution Patent Pool (VDP Pool) in the first half of 2026. "The addition of all of these new Licensors’ patent portfolios is a real win for both the VDP Pool and our many existing and future Licensees,” said Peter Moller, CEO of Access Advance. “These companies have broad and deep patent portfolios and further enhance the program’s market leading position in resolving the licensing issues around the use of modern video codecs across all the diverse business models of internet video streaming.” The following patent holders have joined the VDP Pool as Licensors in the first half of 2026: Digital Insights Inc. Hanbat National University Industry-Academic Cooperation Foundation Hanwha Vision Co., Ltd. Industry-Academy Coopera

Real Chemistry Announces New Asia Pacific Hub with Acquisition of Spurwing Communications in Singapore7.7.2026 01:00:00 CEST | Press release

Expanded footprint advances the company’s global strategy in key growth region for healthcare and pharma brands Real Chemistry, a global leader in AI- and insights-driven healthcare communications, today announced the acquisition of Spurwing Communications, establishing the company’s first Asia Pacific (APAC) strategic hub in Singapore. This milestone strengthens Real Chemistry’s global strategy and presence in APAC, enhancing its ability to support healthcare organizations. Combining deep market expertise with globally integrated capabilities across analytics, medical communications, advertising and strategic communications, the company is well positioned to deliver more connected, local insight-driven support — ultimately helping clients better reach and engage healthcare professionals, patients and caregivers across the region. “APAC is fast becoming one of the most dynamic and strategically important regions for healthcare innovation and access to life-improving therapies,” said Ka

Vertex to Acquire Crinetics Pharmaceuticals6.7.2026 22:04:00 CEST | Press release

- Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex’s portfolio - - PALSONIFY®, Crinetics’ recently launched, first and only, once-daily oral therapy for adults with acromegaly has demonstrated strong and growing early uptake - - Atumelnant, a once-daily oral adrenocorticotropic hormone (ACTH) receptor antagonist in Phase 3 development for congenital adrenal hyperplasia (CAH), has shown unique and transformative potential to both normalize androgen levels and enable management of patients with physiologic levels of glucocorticoids, the true goal of CAH management; atumelnant has also demonstrated therapeutic potential in patients with Cushing’s syndrome - - Acquisition adds to Vertex’s innovation pipeline, accelerates Vertex’s revenue growth and enhances long-term earnings profile - - Vertex to host investor call today, July 6 at 4:30 p.m. ET - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and C

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye